🔓 Unlock the full profile of Nevan Elam (Rezolute, Inc.), including verified contact details, financial insights, and professional associations.
See Nevan Elam Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: nev*****@rez******.com
Mobile: 96885*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Nevan Elam serves as the Founder and CEO of Rezolute, Inc., a biotech company focused on developing transformative therapies for serious diseases.
- Rezolute, Inc. was founded in 2010 and is publicly traded on the NASDAQ under the symbol RZLT, indicating significant growth potential and market presence.
- Under the leadership of Nevan Elam, Rezolute, Inc. has established itself with a market capitalization of $225.2 million, reflecting strong investor confidence.
- Rezolute is known for its innovative approach to drug development, targeting unmet medical needs in conditions such as diabetes and other chronic diseases.
- Nevan Elam has an extensive professional background, including positions on the boards of Savara Pharmaceuticals and Softhale NV, highlighting expertise in managing life sciences companies.
- Prior to founding Rezolute, Elam served as Senior Vice President at Nektar Therapeutics, contributing to advancements in pharmaceutical development.
- As a co-founder and Chief Financial Officer at E2open, Elam played a crucial role in establishing the company’s financial framework and strategic direction.
- Nevan Elam's experience as a corporate partner at Wilson Sonsini Goodrich & Rosati provided valuable insights into legal and business strategies in the biotech sector.
- Rezolute, Inc. has shown impressive growth metrics, with headcount increases of 5.5%, 24.2%, and 45.3% over six, twelve, and twenty-four months, respectively.